Calif First National (CFNB) 14.51 $CFNB Toyota
Post# of 273221
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
Toyota Develops a New DNA Analysis Technology to Dramatically Accelerate Improvements in Agricultural Production
JCN Newswire - Fri Sep 23, 3:09AM CDT
Toyota Motor Corporation (TMC) announces that it has developed a new deoxyribonucleic acid (DNA) analysis technology called Genotyping by Random Amplicon Sequencing (GRAS) using analytical materials that have been provided by the Kyushu Okinawa Agricultural Research Center (KARC) of the National Agriculture and Food Research Organization (NARO). This technology is capable of dramatically improving the efficiency of identifying and selecting useful genetic information for agricultural plant improvement. This newly developed technology should lead to substantial time and cost savings in the agricultural plant improvement process.
TM: 117.10 (-0.56), CFNB: 14.51 (-0.08)
California First National posts 2Q profit
Automated Insights - Fri Jan 29, 4:54PM CST
IRVINE, Calif. (AP) _ California First National Bancorp (CFNB) on Friday reported fiscal second-quarter profit of $1.6 million.
CFNB: 14.51 (-0.08)
CFNB Reports Lower Fourth Quarter Net Earnings of $1.4 Million
BusinessWire - Wed Jul 29, 6:00AM CDT
California First National Bancorp (NASDAQ: CFNB) ("Company"
![](/images/icons/icon_wink.gif)
CFNB: 14.51 (-0.08)
Amplicon introduces 4th generation Ventrix and Impact-R rackmount industrial PCs
M2 - Fri Jul 17, 9:56AM CDT
Amplicon proudly introduce the amazing power of the Intel® Core(TM) 4th generation processor family, unleashing incredible processing power with low power consumption, lower thermal characteristics, and rich I/O.
CFNB: 14.51 (-0.08)
Fluxion Biosciences and Swift Biosciences Announce Jointly Developed Next-Generation Sequencing Workflow for Somatic Mutation Detection From Liquid Biopsy Samples
BusinessWire - Thu May 28, 8:00AM CDT
In advance of the 2015 American Society of Clinical Oncology Annual meeting, Fluxion Biosciences, Inc. and Swift Biosciences, Inc. announced a new workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The jointly-developed workflow utilizes Fluxion's IsoFlux(TM) System for circulating tumor cell (CTC) enrichment and Swift's Accel-Amplicon(TM) technology for high sensitivity variant detection using low starting inputs.
CFNB: 14.51 (-0.08)
CFNB Third Quarter Net Earnings Up 41%
BusinessWire - Tue Apr 21, 5:48PM CDT
California First National Bancorp (NASDAQ:CFNB) ("CalFirst Bancorp"
![](/images/icons/icon_wink.gif)
CFNB: 14.51 (-0.08)
Nasdaq stocks posting largest volume decreases
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
DNBF: 25.92 (+0.47), PPSI: 5.08 (-0.34), OFED: 23.99 (+0.53), SSFN: 7.38 (-0.16), NVSL: 10.95 (-0.02), UNTY: 11.93 (-0.11), CFNB: 14.51 (-0.08), CWAY: 13.32 (-0.18), PSBH: 10.25 (-0.05), MLVF: 16.53 (+0.01), SOCB: 14.02 (+0.16), ITIC: 99.20 (+0.69), MGYR: 10.37 (-0.22)
Amplicon launches brand new expandable rugged tower PC
M2 - Thu Feb 12, 9:35AM CST
The new Impact-T 400 brings power of expansion to the Amplicon embedded family in a tower chassis. Packaged in a lightweight aluminium chassis, designed for optimal heat dissipation, the Impact-T 400 has been designed with card expansion at its heart.
CFNB: 14.51 (-0.08)
A Primer On Financial Sector Players: Research Reports on Bryn Mawr Bank, BSB Bancorp, C&F, Calamos, and CalFirst
PR Newswire - Wed Feb 11, 7:54AM CST
Editor Note: For more information about this release, please scroll to bottom.
CLMS: 6.80 (-0.05), BLMT: 23.22 (-0.27), CFNB: 14.51 (-0.08), CFFI: 42.78 (+0.03), BMTC: 31.18 (-0.54)
CFNB Second Quarter Earnings Up 63%
BusinessWire - Wed Jan 21, 6:00AM CST
California First National Bancorp (NASDAQ: CFNB)("CalFirst Bancorp"
![](/images/icons/icon_wink.gif)
CFNB: 14.51 (-0.08)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)